The court issued the ban after it granted Qualcomm an injunction in a lawsuit against Apple. The ban does not cover the new Apple iPhone XS Plus, iPhone XS and iPhone XR. A court in China has reportedly ruled that it is banning …
The global coalition formed to counter disease epidemics would be investing over $8.4 million for the purpose The tailor-made synthetic vaccine system could fight an array of different pathogens. A global coalition of scientists, established to fight different disease epidemics, is reportedly investing over $8.4 …
The trial is aimed at evaluating the safety and efficacy of AXS-05 in patients with Alzheimer’s disease associated agitation U.S. biopharmaceutical firm, Axsome Therapeutics, Inc., has recently attained positive results in the ADVANCE-1 Phase 2/3 trial of AXS-05 interim analysis. The drug is being developed …
The American retail conglomerate Walmart Inc., has reportedly planned to join forces with Flipkart, the biggest online retail company based in India, with an aim to globally utilize the technological expertise of the Indian online retailer. Reportedly, Walmart is putting in efforts to deploy the …
This proposed new body would apparently be given the power to access the information on how these two corporations adapt their algorithms. The new body would also investigate whether Facebook and Google are favoring their own ventures ahead of other businesses. Reports indicate that Australian …
* The acquisition would be the largest in the Indian software firm’s history. * The two companies already have an ongoing IP partnership for some of the products. HCL Technologies Ltd. (HCL), an Indian multinational software firm has reportedly announced that it would be acquiring …
Seoul based auto maker Kia Motors is reportedly planning to introduce its first India-specific electric vehicle in 2021. To assist in designing a product which is best suited for Indian buyers, consumer-related vehicle inputs like price, battery range, body preference and other issues are being …
A leading American provider of global biopharmaceutical services, Parexel, has recently announced that it is joining forces with Eli Lilly and Company to unveil a new program of clinical research learning & development in China. Reportedly, the program is expected to bring quality training opportunities …
